Recent studies have shown that the genes of the gibberellin (GA) biosynthesis pathway in the fungus Gibberella fujikuroi are organized in a cluster of at least seven genes. P450 -1 is one of four cytochrome P450 monooxygenase genes in this cluster. Disruption of the P450 -1 gene in the GA-producing wild-type strain IMI 58289 led to total loss of GA production. Analysis of the P450 -1-disrupted mutants indicated that GA biosynthesis was blocked immediately after ent-kaurenoic acid. The function of the P450 -1 gene product was investigated further by inserting the gene into mutants of G. fujikuroi that lack the entire GA gene cluster; the gene was highly expressed under GA production conditions in the absence of the other GA-biosynthesis genes. Cultures of transformants containing P450 -1 converted ent- cytochrome P450 ͉ ent-kaurenoid metabolism ͉ GA14 synthase
ibberellins (GAs) constitute a large family of tetracyclic diterpenoid carboxylic acids, some members of which function as growth hormones in higher plants, promoting processes such as seed germination, stem elongation, flower development, and fruit growth (1) . GAs were first identified as secondary products of the fungus Gibberella fujikuroi (mating population C) and are also produced by other fungal species (2) (3) (4) . The early steps of the GA-biosynthetic pathway from transgeranylgeranyl diphosphate to GA 12 -aldehyde ( Fig. 1 ) are identical for plants and fungi, but the pathways diverge thereafter. The major end product of the pathway in G. fujikuroi is gibberellic acid (GA 3 ), which is a minor GA component in most plant species.
Considerable progress has been made in isolating and characterizing the genes of GA biosynthesis in plants (5) . These include genes encoding the membrane-associated cytochrome P450-monooxygenases and soluble dioxygenases that catalyze, respectively, intermediate and late steps of the pathway. Recently, the genes involved in GA biosynthesis in G. fujikuroi were found to be organized in a cluster containing at least seven genes (ref. 6 and unpublished work). The identification of these genes has provided the opportunity to study the fungal enzymes and metabolic steps they catalyze, which had previously proved difficult at the protein level (2) . It has been possible to demonstrate enzyme activities in vitro for only the early part of the fungal GA pathway; these activities include the formation (7) and metabolism (8) of the intermediate, ent-kaurene, the 7␤-hydroxylation of ent-kaurenoic acid (9) , and the conversion of GA 12 -aldehyde to GA 14 (10) . Each of these reactions after ent-kaurene is catalyzed by microsomal monooxygenases with the properties expected for cytochrome P450s.
Approximately 18 steps are required for the formation of GA 3 from transgeranylgeranyl diphosphate (GGPP), yet the cluster apparently contains only seven genes, one of which is GGPP synthase (6) . The limited number of genes suggests that either not all of the genes have been identified or some genes encode multifunctional enzymes. On the basis of amino acid sequence similarities (ref. 6 and unpublished work), four of the seven genes in the GA-biosynthesis cluster in G. fujikuroi appear to encode cytochrome P450 monooxygenases. These genes are designated P450-1, P450-2, P450-3, and P450-4; the P450-1 gene is closely linked to P450-4 in the gene cluster, sharing the same promoter Abbreviation: GA, gibberellin. § To whom reprint requests should be addressed. E-mail: Bettina.Tudzynski@uni-muenster.de.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Fig. 1 . Biosynthetic pathways to GAs and ent-kaurenoids in G. fujikuroi, indicating the reactions we propose to be catalyzed by P450 -1 (between dotted lines). Thick arrows depict proposed major pathway from entkaurenoic acid to GA 14. sequence but being transcribed in the opposite direction (Fig. 2) . P450-1 is classified with P450-2 in the family CYP68 (6) . In the present study, we have used two methods to characterize its function in the GA-biosynthetic pathway. We have shown by disruption of P450-1 that the gene is involved in the conversion of ent-kaurenoic acid. Furthermore, by expressing P450-1 in a G. fujikuroi mutant lacking the entire gene cluster, we have demonstrated that the gene product catalyzes four steps in the metabolism of ent-kaurenoic acid to GA 14 . Our results also indicate that P450-1 is responsible for the formation of entkaurenoid-derived by-products of the GA-biosynthetic pathway.
Materials and Methods
Fungal Strains and Culture Conditions. The wild-type strain G. fujikuroi IMI 58289 and the GA-defective mutant strain SG139 (11) were kindly provided by E. Cerda-Olmedo and J. Avalos (University of Sevilla, Sevilla, Spain).
Bacterial Strains and Plasmids. For gene replacement experiments, a 6.5-kb SalI fragment carrying the P450-1 gene was cloned into pUC19 with a deleted SphI site (pUC19⌬SphI). An internal 1,519-bp fragment of this genomic SalI fragment was excised with SphI and replaced by a 2.5-kb SphI fragment from the vector pAN7-1 (12) , carrying the hygromycin B resistance cassette. For gene complementation, a 4-Kb HindIII fragment carrying the whole P450-1 gene was cloned into pAN7-1 to give p450-1-GC.
Media and Culture Conditions. For DNA isolation, fungal strains were grown in complete liquid medium optimized for Fusarium spp (100 ml) (13) for 3 days at 28°C on a rotary shaker set at 200 rpm. The mycelium was harvested by filtration through a sterile glass filter (G2, Schott Jena, Jena, Germany), washed with sterile distilled water, frozen in liquid nitrogen, and lyophilized for 24 h. The lyophilized mycelial tissue was ground into a fine powder. For RNA isolation, the fungal strains were grown in 20% ICI medium (14) for 48 h on a rotary shaker at 28°C. Cultures for metabolism studies were established in 100% ICI medium (100 ml) for 4 days at 25°C on a rotary shaker, then subcultured into 40% ICI medium (100 ml) and, after 5 days, into 10% ICI medium containing 1 mM AMO-1618 (Calbiochem) (100 ml).
Southern and Northern Blot Analysis. Genomic DNA was isolated from lyophilized mycelium according to ref. 15 . Plasmid DNA was extracted by using Genomed columns following the manufacturer's protocol (Genomed, Bad Oeynhausen, Germany). After endonuclease digestion and electrophoresis, genomic DNA was transferred onto Hybond N ϩ filters (Amersham Pharmacia). The 32 P-labeled probes were prepared by using the random oligomer-primer method. Filters were hybridized at 65°C in 5 ϫ Denhardt's solution (0.02% polyvinylpyrrolidone͞0.02% Ficoll͞0.02% BSA containing 5% dextran sulfate) (16) . Filters were washed at the hybridization temperature in 2 ϫ 0.18 M NaCl͞10 mM phosphate, pH 7.4͞1 mM EDTA (SSPE)͞0.1% SDS, and 1 ϫ SSPE͞0.1% SDS.
RNA was isolated by using the RNAgents Total RNA Isolation Kit (Promega). Northern blot hybridization was accomplished by the method of Church and Gilbert (17) . The conserved Botrytis cinerea actin gene (J. van Kan, personal communication) was used as a control for RNA transfer.
Transformation of G. fujikuroi. Preparation of protoplasts and the transformation procedure were carried out as described (18) . For gene replacement, 10 7 protoplasts (100 l) of strain IMI 58289 were transformed with 10 g of the SacI-digested gene replacement vector P450-1-GR. For complementation of the mutant strain SG139 with the intact P450-1 gene, protoplasts of SG139 were transformed with 10 g of the circular complementation vector P450-1-GC. For complementation of the restriction enzyme-meditated integration-deletion mutant Gib1 (18) carrying an additional nia-D mutation, a cotransformation was performed by using 10 g each of the vector P450-1-GK and the vector pJ1, containing the intact G. fujikuroi niaD gene (19) .
Transformed protoplasts were regenerated at 28°C in a complete regeneration agar [0.7 M sucrose͞0.05% yeast extract͞0.1% (NH 4 ) 2 SO 4 ] containing 120 g͞ml of hygromycin B (Calbiochem) for 6-7 days or, in the case of cotransformation, in a stabilized (0.8 M KCl) Czapex-Dox agar (Merck). Single conidial cultures were established from hygromycin B-resistant transformants and used for DNA isolation and Southern blot analysis.
PCRs. G. fujikuroi genomic DNA (50 ng) was used as template for amplification of the P450-1 gene in the wild type and transformants of strain SG139 with the P450-1 gene copy. The specific primers (50 ng), which were synthesized by MWG-Biotech (Munich), had the following sequences: forward (P450-1-F), 5Ј-TAT ACA CCC TCG CCT GTG AGG G-3Ј; reverse (P450-1-R), 5Ј-GTG AGG AGA CTT GCC GTC ATA GG-3Ј. DNA amplification was performed in 50-l mixtures by using 2 units of Taq DNA polymerase (Red-Taq, Sigma-Aldrich). PCR was carried out for 36 cycles, each comprising 1 min denaturation at 94°C, 0.5 min annealing at 56°C, and 1.5 min synthesis at 72°C.
GA Analysis. For analysis of GA formation, strain IMI 58289 and P450-1-disrupted mutants were cultivated in 100-ml Erlenmeyer flasks containing 20 ml of 20% ICI medium. The cultures were incubated for 7 days on a rotary shaker (200 rpm) at 28°C. GA production was determined by HPLC (20) by using a Merck HPLC system with a Lichrispher 100 RP18 column (5 m; 250 ϫ 4; Merck) or by TLC (18) . Extracts of culture filtrates and mycelia were analyzed by combined GC͞MS, as described previously (18 were prepared from R-[2-14 C]mevalonic acid (Amersham Pharmacia) by using a cell-free system from pumpkin endosperm, as described (21) . Fungal cultures, grown in 40% ICI medium for 2 days at 28°C, were harvested and the mycelia washed with 0% ICI medium (15) . For experiments to characterize SG139 transformants, mycelia were resuspended in 0% ICI and 1-ml aliquots transferred to 25-ml sterile flasks containing 5 ml of the same medium. The radiolabeled substrates (500 Bq per flask) or ent-[17-2 H]kaurenoic acid (20 g to 4 mg per flask) were added to the cultures in methanol (10-40 l). After incubation on an orbital shaker at 28°C for 2 days, cultures were filtered, and filtrates were adjusted to pH 3.0 with 2 M HCl and partitioned against ethyl acetate (3 ϫ equal volume). The combined organic layers were evaporated under vacuum and the residue dissolved in 20% methanol͞H 2 O, pH 3.0. This solution was applied to a C 18 cartridge (SepPak, Waters) and the products eluted with methanol and further analyzed by HPLC on a C 18 column (Symmetry, Waters) in a Waters 600 instrument by using a linear gradient from 60 to 100% methanol͞H 2 O, pH 3.0, over 15 min, followed by 100% methanol for 15 min. The flow rate was 1 ml͞min. Fractions (1 ml) were collected and the radioactivity measured by liquid scintillation counting.
For incubations with P450-1-disrupted mutants, radiolabeled substrates (2-4 kBq) were added in methanol (20-50 l) to 5-day-old cultures in 10% ICI medium (5 ml) in sterile 50 ml Falcon tubes. After incubation on an orbital shaker at 25°C for 3 days, the cultures were filtered and the filtrates extracted, as described above. The mycelia were extracted with 10 ml of methanol overnight, the extracts passed although silica gel (500 mg), which was eluted with a further 10 ml of methanol, and the combined eluates taken to dryness in vacuo. The extracts were analyzed by reverse-phase HPLC on a C18 Hypersil column (25 ϫ 0.46 cm) with on-line radioactivity monitoring (22) ; culture extracts were eluted with a linear gradient of 20-100% solvent B over 24 min at 1 ml⅐min Ϫ1 , after which the column was eluted with solvent B for a further 5 min (solvent A, 10% methanol-water; solvent B, methanol, each containing 50 l⅐liter Ϫ1 acetic acid) and mycelial extracts, by using a gradient of 75-100% B over 30 min followed by 30 min with B.
Microsomes were prepared from the mycelia of the SG139-T7 transformant as described previously (10) (10, 000 dpm) in the presence of 1 mM NADPH and 5 M FAD in a final volume of 100 l. Products were extracted and analyzed by HPLC, as described (10) .
Results
Disruption of P450 -1. The P450-1 gene was mapped between P450-4 and P450-2 in the GA biosynthesis gene cluster (Fig.  2 A) . It was shown in a previous experiment (6) that replacement of a central part of genes P450-1 and P450-2 led to the loss of GA biosynthesis. To identify the biosynthetic steps in which the P450-1 gene product is involved, the P450-1 locus was specifically inactivated in the wild-type strain IMI 58289 by transformation with the linearized replacement vector, P450-1-GR, containing the hygromycin resistance cassette as selection marker (Fig. 2B) . Among the 35 transformants generated, two, ⌬P450-1-T9 and -T35, failed to produce GAs when cultured in a GA production medium. Southern blot analysis of genomic DNA from these two transformants and the wild-type after digestion with HindIII and PstI and probing with the 460-bp P450-1 cDNA fragment (see Fig. 2 ) indicated clear differences (Fig. 3A) . The probe hybridized to a 4.0-kb HindIII and a 4.3-kb PstI fragment from the wild-type strain and to 5.0-kb HindIII and 1.8-kb PstI fragments (because of an additional PstI-site in the hygromycin cassette) from the transformants. These restriction patterns were consistent with a double-crossover event between the disruption vector and the P450-1 locus. Northern blot analysis revealed two transcripts in ⌬P450-1-T9 and -T35 of altered lengths and lower abundance compared with the 1.6-kb transcript from the wild type (Fig. 3B) . The larger transcript may be produced from reading through the terminator of the hygromycin B resistance cassette, but the origin of the smaller transcript is unclear.
The wild-type strain and T35 were grown under GA-inducing conditions for 5 days, after which the culture filtrate and mycelia were analyzed by full-scan GC͞MS (Fig. 4A) . The culture filtrate from the wild type contained mainly GA 3 , with lower amounts of GA 13 , and 7␤,18-dihydroxykaurenolide. The isolactone of GA 3 , which was also present, may be an artifact of the chromatography. Strain ⌬P450-1-T35 accumulated ent-kaurenoic acid in the mycelium but not later intermediates in the culture filtrate (Fig. 4A) , so that the block appeared to be in the conversion of ent-kaurenoic acid to ent-7␣-hydroxykaurenoic acid. To confirm this, we incubated T35 and the wild-type strain with 14 C-labeled ent-kaurenoic acid and GA 12 -aldehyde. The mutant strain T35 metabolized neither ent-kaurenoic acid, which accumulated in the mycelia (Fig. 4B) , nor GA 12 -aldehyde, which was extracted from the culture filtrate (Fig. 4C) . The wild-type strain converted both intermediates efficiently to GA 3 . These results suggest that the P450-1 enzyme catalyzes not only the conversion of entkaurenoic acid but also at least one subsequent oxidative step in the pathway.
Functional Analysis of P450 -1. To define precisely the metabolic steps catalyzed by the P450-1 enzyme, we transformed the GA-deficient mutant strain SG139 with the gene complemen- tation vector, pP450-1-GC, carrying the whole wild-type P450-1 gene. Mutant SG139, which was produced by UV treatment (11), lacks the entire GA gene cluster, as demonstrated by Southern blot (see Fig. 3A ) and PCR analysis (data not shown). In an additional experiment, the GA-deficient mutant Gib1, which also lacks the GA gene cluster as part of an Ϸ300-Kb fragment that was lost from chromosome IV after restriction enzymemeditated integration (18) , was also transformed with pP450-1-GC. Of 45 transformants analyzed, 38 contained the expected 2,310-bp PCR fragment between primers P450-1-F and P450-1-R. To confirm that the gene is expressed in the transformants, Northern blot analysis was performed on five PCR-positive lines derived from SG139 (SG139-T7, -T8, -T10, -T15, and -T32), one transformant that did not reveal a PCR fragment of the expected size (SG139-T20), and one PCR-positive line (Gib1-T6) derived from Gib1. IMI58289, SG139, and Gib1 were also analyzed as controls. As shown in Fig. 5, P450-1 is expressed in all PCRpositive transformants tested and in the wild-type strain. No transcript for P450-1 was present in the deletion mutants SG139 and Gib1 or in SG139-T20.
Three SG139 transformants (SG139-T7, SG139-T10, and SG139-T32) and one transformant of Gib1 (Gib1-T6) were incubated for 2 days with ent-[ 12 (not with Gib1-T6) under GA-inducing conditions, and the products were analyzed by HPLC (shown for SG139-T32 in Fig. 6 ). Each transformant metabolized all four substrates, the major product in each case having a retention time (Rt) of 13-14 min. The main radiolabeled compound in this fraction was identified by GC͞MS as [ 14 
Discussion
We have used two methods to determine the function of the cytochrome P450 monooxygenase encoded by P450-1, one of a cluster of seven genes involved in GA biosynthesis in G. fujikuroi. First, specific disruption of this gene in a GA-producing strain of the fungus indicated that the encoded enzyme catalyzed the 7␤-hydroxylation of ent-kaurenoic acid. However, we showed that at least one later step in the pathway was also affected by disrupting P450-1. Second, we examined the function of P450-1 in the absence of the other GA-biosynthetic enzymes by expressing the gene in G. fujikuroi mutants that lacked the GAbiosynthesis gene cluster. By this means, we could demonstrate that the enzyme converts ent-kaurenoic acid to GA 14 and thus catalyzes four steps in the GA-biosynthetic pathway: hydroxylation at C-7, oxidation at C-6 resulting in contraction of ring B (24, 25) , 3␤-hydroxylation, and finally oxidation at C-7 (Fig. 1) . Intermediates in this sequence, ent-7␣-hydroxykaurenoic acid and GA 12 -aldehyde, as well as GA 12 , which is not thought to be a normal precursor of 3␤-hydroxylated GAs (26), were converted efficiently by the enzyme to GA 14 . Even when entkaurenoic acid was applied at very high concentrations, GA 14 was the predominant product, and only low amounts of ent-7␣-hydroxykaurenoic acid and GA 12 were found in the culture medium. This result suggests that the first step in the reaction sequence may limit the overall reaction rate, although uptake of the substrates into the cell may be the limiting factor.
Microsomes from G. fujikuroi have been shown to catalyze the reaction sequence from ent-kaurenoic acid to GA 12 and GA 14 (9, 10, 27) . However, microsomal preparations failed to convert GA 12 to GA 14 by 3␤-hydroxylation, regardless of whether they were prepared from a wild-type strain (10) or from the P450-1 transformants (this work). This apparent inconsistency between the experiments by using intact cultures of the P450-1 transformants and those with microsomal preparations could be explained if GA 12 is a relatively poor substrate for 3␤-hydroxylation. If GA 12 is converted to GA 14 at a slow rate, this reaction could occur only in cultures of the P450-1 transformant, where the substrate is in contact with high levels of enzyme for long periods of time in the absence of competing enzyme activities. Thus, the major pathway to GA 14 is presumably via GA 14 -aldehyde (23), which was not detected as an intermediate in the present study. In our experiments, the wild-type strain converted GA 12 to nonpolar products, consistent with the results of Bearder et al. (28) , who found that GA 12 is metabolized mainly to the non-3␤-hydroxylated GA, GA 9 . The small amount of GA 3 formed from GA 12 may be the result of the low rate of 3␤-hydroxylation.
We provide evidence to suggest that P450-1, as well as catalyzing reactions of the GA-biosynthetic pathway, may be involved in two branch pathways, those from ent-kaurenoic acid to the kaurenolides and those from ent-7␣-hydroxykaurenoic acid to seco-ring B products (3) (Fig. 1) . We detected 7␤-hydroxy-, 3␤,7␤-dihydroxy-, and 7␤,18-dihydroxykaurenolides together with fujenoic acid as products after incubations of ent-kaurenoic acid with cultures of the P450-1 transformants, whereas the deletion mutants lacking the P450-1 gene failed to metabolize ent-kaurenoic acid or ent-7␣-hydroxykaurenoic acid. Furthermore, the transformants formed fujenoic acid and fujenoic triacid from ent-6␣,7␣-dihydroxykaurenoic acid, whereas the deletion mutants did not metabolize this intermediate. ent-6␣,7␣-dihydroxykaurenoic acid, which was postulated as the precursor of the seco-ring B products (29) , has been shown to be formed together with GA 12 -aldehyde in cell-free preparations from pumpkin endosperm by oxidation of ent-7␣-hydroxykaurenoic acid on C-6 (25) . Full confirmation for the involvement of P450-1 in the branch pathways will require demonstration of each metabolic step in the P450-1 transformants and its absence in the disruption or deletion mutants. However, the seven reactions required for the branch pathways (Fig. 1) , involving oxidation on C-3, C-6, C-7, and C-18, are consistent with the demonstrated activities of P450-1 for the conversion of entkaurenoic acid to GA 14 .
Sequential oxidations at a single carbon atom that are mediated by cytochrome P450s have been described as, for example, in the loss of C-14 in steroid biosynthesis (30) and the three-step oxidation of ent-kaurene to ent-kaurenoic acid in G. fujikuroi (8) . However, the reactions catalyzed by P450-1 involve oxidations The mass spectrometric data are provided as Table 2 , which is published as supplemental data on the PNAS web site, www.pnas.org. *Total extracts of culture filtrates were analyzed by GC͞MS. Otherwise, extracts were separated by HPLC, and fractions containing radioactivity were analyzed.
at four different carbon atoms, C-6, C-7, C-3, and C-18, most of which are nonadjacent. Oxidation at multiple sites by a single P450 enzyme has been reported for monooxygenases involved in mammalian steroid biosynthesis as, for example, in the 11␤-and 18-hydroxylation of 11-deoxycorticosterone by porcine adrenocortical cytochrome P450 (11␤) (31) and 11␤-, 18-, and 19-hydroxylations of the same steroid by rat cytochrome P450 (11␤) (32) . Furthermore, in the fungus Curvularia lunata, 11-deoxycortisol is hydroxylated at positions 11␤ and 14␣ by the same P450 monooxygenase (33) . P450-1 contains a single heme-binding motif so that all reactions catalyzed, which include oxidations at seemingly remote carbon centers, must occur at the same active site. However, depending on conformation, the sites oxidized by P450-1, for example C-3␤ and C-7 in GA 12 -aldehyde, are sufficiently close that little change in substratebinding orientation may be required for either reaction to take place. Differences in the requirement for FAD for GA 12 aldehyde 7-oxidase and 3␤-hydroxylase activities (10) might suggest interaction of the P450-1 heme with different electron transport proteins for these two reactions. A small change in the binding orientation of 7␤-hydroxykaurenolide relative to that of ent-7␣-hydroxykaurenoic acid would allow the former substrate, but not the latter, to be hydroxylated at C-18 or C-3␤. Analysis of its secondary structure indicates that P450-1, in common with most eukaryotic cytochrome P450s, contains a single membrane-spanning domain at its N terminus. However, the enzyme is apparently loosely bound to the microsomal fraction, as it can be easily solubilized in the presence of high salt concentrations (9) .
We have recently become aware of parallel work showing that barley and Arabidopsis contain cytochrome P450 monoxygenases with catalytic activity similar to that of P450-1 (34). The plant enzymes, which belong to the CYP88A subfamily, convert ent-kaurenoic acid to GA 12 . There must, however, be important differences between the fungal and plant enzymes because in plants, 3␤-hydroxylation is catalyzed by 2-oxoglutaratedependent dioxygenases and, in most cases, occurs late in the pathway, after C-20 has been removed (see ref. 5). The plant enzymes responsible for GA 12 synthesis are not apparently capable of 3␤-hydroxylation.
The involvement of dioxygenases in GA biosynthesis in plants has been shown for oxidation at C-20, C-2␤, C-3␤, and, in pumpkin, C-7. Oxidation at C-20, resulting in the loss of this C atom, occurs also in G. fujikuroi. However, as no dioxygenase genes have been identified within the GA-biosynthesis gene cluster of the fungus, it seems likely that the 20-oxidase is a different type of enzyme in G. fujikuroi, most probably a cytochrome P450. The conversion of GA 12 -aldehyde to GA 12 (7-oxidation) in pumpkin seed can be catalyzed by either monooxygenase or dioxygenase activities (35, 36) , but it is not known whether the dioxygenase is of more general significance. In Arabidopsis, there are no candidate dioxygenases GA 7-oxidase genes (37) , so it appears likely that this activity is caused solely by a monooxygenase.
Research of GA biosynthesis has reached an exciting stage in plants and in G. fujikuroi. As more genes and enzymes are characterized, it is becoming clear that very significant differences exist in the genetics and biochemistry of GA biosynthesis in plants and fungus. For example, they differ in the organization of the genes, in the nature and substrate specificities of the enzymes, and in the mechanisms of regulation. For G. fujikuroi, most of the genes are now available, allowing new opportunities for detailed studies of their regulation. Furthermore, mutants lacking the GA-biosynthesis gene cluster provide a highly efficient and convenient expression system for the preparation of enzymes for studies of function and structure. 
